- Protocol Short Name and Number: NST Haploidentical, 0603
- Protocol Long Name: A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients with Hematologic Malignancies
- Protocol (PDF)
- Informed Consent
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0603 Protocol Co-chair: Ephraim Fuchs, MD
- BMT CTN # 0603 Protocol Co-chair: Paul O’Donnell, MD
- BMT CTN # 0603 Protocol Officer: Mary Eapen, MD
- BMT CTN # 0603 Protocol Coordinator: bmtctn@emmes.com
- BMT CTN # 0603 Medical Monitor: Shannon Smiley, MD
- Keywords: Allo Transplant, Allogeneic Transplant, Allo, Haplo, Haploidentical, Non-Myeloablative, Hematologic malignancies, Leukemia, Lymphoma, Pediatric, Child, Children, Teen, Adolescent
This Study reached its target patient accrual on May 17, 2010 and is closed to new enrollment.